Eldamária De Vargas Wolfgramm Dos Santos

Dr. Eldamária De Vargas Wolfgramm Dos Santos


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2023 in Genes
Verified
Journal Article
Open access
PDF file
LALyvia Neves Rebello Alves
Lyvia Neves Rebello Alves
DMDébora Dummer Meira
Débora Dummer Meira
LMLuiza Poppe Merigueti
Luiza Poppe Merigueti
MCMatheus Correia Casotti
Matheus Correia Casotti
DVDiego Ventorim
Diego Ventorim
ILIuri Drumond Louro
Iuri Drumond Louro
Breast cancer is the second most frequent cancer in the world. It is a heterogeneous disease and the leading cause of cancer mortality in women. Advances in molecular technologies allowed for the identification of new and more specifics biomarkers for breast cancer diagnosis, prognosis, and risk prediction, enabling personalized treatments, improving therapy, and preventing overtreatment, undertreatment, and incorrect treatment. Several breast cancer biomarkers have been identified and, along with traditional biomarkers, they can assist physicians throughout treatment plan and increase therapy success. Despite the need of more data to improve specificity and determine the real clinical utility of some biomarkers, others are already established and can be used as a guide to make treatment decisions. In this review, we summarize the available traditional, novel, and potential biomarkers while also including gene expression profiles, breast cancer single-cell and polyploid giant cancer cells. We hope to help physicians understand tumor specific characteristics and support decision-making in patient-personalized clinical management, consequently improving treatment outcome.

7 September 2022 in Genes
Verified
Journal Article
Open access
PDF file
FGFernanda Mariano Garcia
Fernanda Mariano Garcia
BBBárbara G. O. Bessa
Bárbara G. O. Bessa
ESEldamária De Vargas Wolfgramm Dos Santos
Eldamária De Vargas Wolfgramm Dos Santos
JPJulia Del Piero Pereira
Julia Del Piero Pereira
LALyvia Neves Rebello Alves
Lyvia Neves Rebello Alves
ILIuri Drumond Louro
Iuri Drumond Louro
Microsatellite genetic markers are the gold standard for human genetic identification. Forensic analyses around the world are carried out through protocols using the analysis of STR markers in autosomal chromosomes and in the Y chromosome to solve crimes. However, these analyses do not allow for the resolution of all cases, such as rape situations with suspicion of incest, paternity without a maternal sample for comparison, and biological traces with DNA mixture where the profile sought is female, among other situations. In these complex cases, the study of X-chromosome STR markers significantly increases the probability of identification by complementing the data obtained for autosomal and Y-chromosome markers, due to the unique structure of the X chromosome and its exclusive method of inheritance. However, there are currently no validated Brazilian protocols for this purpose, nor are there any population data necessary for statistical analyses that must be included in the issuance of expert reports. Thus, the aim of this article is to provide a literary review of the applications of X-chromosomal markers in population genetics.

26 March 2023 in Genes
Verified
Journal Article
Open access
PDF file
MCMatheus Correia Casotti
Matheus Correia Casotti
DMDébora Dummer Meira
Débora Dummer Meira
AZAléxia Stefani Siqueira Zetum
Aléxia Stefani Siqueira Zetum
BABruno Cancian De Araujo
Bruno Cancian De Araujo
DSDanielle Ribeiro Campos da Silva
Danielle Ribeiro Campos da Silva
ILIuri Drumond Louro
Iuri Drumond Louro
Precision and organization govern the cell cycle, ensuring normal proliferation. However, some cells may undergo abnormal cell divisions (neosis) or variations of mitotic cycles (endopolyploidy). Consequently, the formation of polyploid giant cancer cells (PGCCs), critical for tumor survival, resistance, and immortalization, can occur. Newly formed cells end up accessing numerous multicellular and unicellular programs that enable metastasis, drug resistance, tumor recurrence, and self-renewal or diverse clone formation. An integrative literature review was carried out, searching articles in several sites, including: PUBMED, NCBI-PMC, and Google Academic, published in English, indexed in referenced databases and without a publication time filter, but prioritizing articles from the last 3 years, to answer the following questions: (i) “What is the current knowledge about polyploidy in tumors?”; (ii) “What are the applications of computational studies for the understanding of cancer polyploidy?”; and (iii) “How do PGCCs contribute to tumorigenesis?”

6 February 2023 in Genes
Verified
Journal Article
Open access
PDF file
MCMatheus Correia Casotti
Matheus Correia Casotti
DMDébora Dummer Meira
Débora Dummer Meira
LALyvia Neves Rebello Alves
Lyvia Neves Rebello Alves
BBBarbara Gomes de Oliveira Bessa
Barbara Gomes de Oliveira Bessa
CCCamilly Victória Campanharo
Camilly Victória Campanharo
ILIuri Drumond Louro
Iuri Drumond Louro
Translational Bioinformatics (TBI) is defined as the union of translational medicine and bioinformatics. It emerges as a major advance in science and technology by covering everything, from the most basic database discoveries, to the development of algorithms for molecular and cellular analysis, as well as their clinical applications. This technology makes it possible to access the knowledge of scientific evidence and apply it to clinical practice. This manuscript aims to highlight the role of TBI in the study of complex diseases, as well as its application to the understanding and treatment of cancer. An integrative literature review was carried out, obtaining articles through several websites, among them: PUBMED, Science Direct, NCBI-PMC, Scientific Electronic Library Online (SciELO), and Google Academic, published in English, Spanish, and Portuguese, indexed in the referred databases and answering the following guiding question: “How does TBI provide a scientific understanding of complex diseases?” An additional effort is aimed at the dissemination, inclusion, and perpetuation of TBI knowledge from the academic environment to society, helping the study, understanding, and elucidating of complex disease mechanics and their treatment.

4 October 2023 in Genes
Verified
Journal Article
Open access
PDF file
DMDébora Dummer Meira
Débora Dummer Meira
MCMaria Clara de Castro e Caetano
Maria Clara de Castro e Caetano
MCMatheus Correia Casotti
Matheus Correia Casotti
AZAléxia Stefani Siqueira Zetum
Aléxia Stefani Siqueira Zetum
AGAndré Felipe Monteiro Gonçalves
André Felipe Monteiro Gonçalves
ILIuri Drumond Louro
Iuri Drumond Louro
Lung cancer is a highly aggressive neoplasm and, despite the development of recent therapies, tumor progression and recurrence following the initial response remains unsolved. Several questions remain unanswered about non-small cell lung cancer (NSCLC): (1) Which patients will actually benefit from therapy? (2) What are the predictive factors of response to MAbs and TKIs? (3) What are the best combination strategies with conventional treatments or new antineoplastic drugs? To answer these questions, an integrative literature review was carried out, searching articles in PUBMED, NCBI-PMC, Google Academic, and others. Here, we will examine the molecular genetics of lung cancer, emphasizing NSCLC, and delineate the primary categories of inhibitors based on their molecular targets, alongside the main treatment alternatives depending on the type of acquired resistance. We highlighted new therapies based on epigenetic information and a single-cell approach as a potential source of new biomarkers. The current and future of NSCLC management hinges upon genotyping correct prognostic markers, as well as on the evolution of precision medicine, which guarantees a tailored drug combination with precise targeting.

1 January 2020 in Genetics and Molecular Biology
Verified
Journal Article
Open access
PDF file
RRRaquel Silva dos Reis
Raquel Silva dos Reis
JSJéssica Aflávio dos Santos
Jéssica Aflávio dos Santos
PAPriscila Marinho de Abreu
Priscila Marinho de Abreu
RDRaquel Spinassé Dettogni
Raquel Spinassé Dettogni
ESEldamária De Vargas Wolfgramm Dos Santos
Eldamária De Vargas Wolfgramm Dos Santos
ILIúri Drumond Louro
Iúri Drumond Louro
Squamous cell carcinoma of the oral cavity and oropharynx is the sixth most common type of cancer in the world. During tumorigenesis, gene promoter hypermethylation is considered an important mechanism of transcription silencing of tumor suppressor genes, such as DAPK, MGMT and RUNX3. These genes participate in signaling pathways related to apoptosis, DNA repair and proliferation whose loss of expression is possibly associated with cancer development and progression. In order to investigate associations between hypermethylation and clinicopathological and prognostic parameters, promoter methylation was evaluated in 72 HPV negative oral and oropharyngeal tumors using methylation-specific PCR. Hypermethylation frequencies found for DAPK, MGMT and RUNX3 were 38.88%, 19.44% and 1.38% respectively. Patients with MGMT hypermethylation had a better 2-year overall survival compared to patients without methylation. Being MGMT a repair gene for alkylating agents, it could be a biomarker of treatment response for patients who are candidates for cisplatin chemotherapy, predicting drug resistance. In view of the considerable levels of hypermethylation in cancer cells and, for MGMT, its prognostic relevance, DAPK and MGMT show potential as epigenetic markers, in a way that additional studies may test its viability and efficacy in clinical management.